William Roland Mann - Net Worth and Insider Trading

William Roland Mann Net Worth

The estimated net worth of William Roland Mann is at least $4,234 dollars as of 2024-06-04. William Roland Mann is the COO of NeuBase Therapeutics Inc and owns about 11,200 shares of NeuBase Therapeutics Inc (NBSE) stock worth over $4,234. Details can be seen in William Roland Mann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William Roland Mann has not made any transactions after 2022-03-30 and currently still holds the listed stock(s).

Transaction Summary of William Roland Mann

To

William Roland Mann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William Roland Mann owns 1 companies in total, including NeuBase Therapeutics Inc (NBSE) .

Click here to see the complete history of William Roland Mann’s form 4 insider trades.

Insider Ownership Summary of William Roland Mann

Ticker Comapny Transaction Date Type of Owner
NBSE NeuBase Therapeutics Inc 2022-03-30 COO

William Roland Mann Latest Holdings Summary

William Roland Mann currently owns a total of 1 stock. William Roland Mann owns 11,200 shares of NeuBase Therapeutics Inc (NBSE) as of March 30, 2022, with a value of $4,234.

Latest Holdings of William Roland Mann

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBSE NeuBase Therapeutics Inc 2022-03-30 11,200 0.38 4,234

Holding Weightings of William Roland Mann


William Roland Mann Form 4 Trading Tracker

According to the SEC Form 4 filings, William Roland Mann has made a total of 2 transactions in NeuBase Therapeutics Inc (NBSE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in NeuBase Therapeutics Inc is the acquisition of 6,200 shares on March 30, 2022, which cost William Roland Mann around $11,904.

Insider Trading History of William Roland Mann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William Roland Mann Trading Performance

GuruFocus tracks the stock performance after each of William Roland Mann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Roland Mann is -40.05%. GuruFocus also compares William Roland Mann's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Roland Mann within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how William Roland Mann's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of William Roland Mann

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -24.92 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -19.91 LIMIT LIMIT LIMIT LIMIT LIMIT

William Roland Mann Ownership Network

Ownership Network List of William Roland Mann

No Data

Ownership Network Relation of William Roland Mann

Insider Network Chart

William Roland Mann Owned Company Details

What does NeuBase Therapeutics Inc do?

Who are the key executives at NeuBase Therapeutics Inc?

William Roland Mann is the COO of NeuBase Therapeutics Inc. Other key executives at NeuBase Therapeutics Inc include 10 percent owner Symetryx Corp , 10 percent owner Barry Shiff , and 10 percent owner Aleta Shiff .

NeuBase Therapeutics Inc (NBSE) Insider Trades Summary

Over the past 18 months, William Roland Mann made no insider transaction in NeuBase Therapeutics Inc (NBSE). Other recent insider transactions involving NeuBase Therapeutics Inc (NBSE) include a net sale of 428,444 shares made by Symetryx Corp ,

In summary, during the past 3 months, insiders sold 0 shares of NeuBase Therapeutics Inc (NBSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 489,520 shares of NeuBase Therapeutics Inc (NBSE) were sold and 61,076 shares were bought by its insiders, resulting in a net sale of 428,444 shares.

NeuBase Therapeutics Inc (NBSE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NeuBase Therapeutics Inc Insider Transactions

No Available Data

William Roland Mann Mailing Address

Above is the net worth, insider trading, and ownership report for William Roland Mann. You might contact William Roland Mann via mailing address: 700 Technology Drive, Pittsburgh Pa 15219.

Discussions on William Roland Mann

No discussions yet.